PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Reproductive health: Checkerboard of infertility treatment in Europe

In a number of European countries, infertility patients are limited in their choice for medically assisted reproduction treatment, experts criticized today at the European Health Forum Gastein. Many patients seek treatment outside their home countries

2010-10-07
(Press-News.org) Bad Hofgastein, 6 October 2010 -- European patients are in many countries, in fact, limited in their individual choice of medically assisted reproduction (MAR) treatment, experts from the European Society of Human Reproduction and Embryology (ESHRE) stressed today at the European Health Forum Gastein (EHFG).

The EHFG is the most important conference on health care policy in the EU. This year it has attracted about 600 decision-makers from more than 40 countries in the fields of health care policy, research, science, and business as well as from patients' organizations.

During an ESHRE workshop the political, professional, industrial and patient perspectives highlighted the problems related to the patchwork of MAR regulation in Europe. The regulatory diversity in MAR is attributed to the religious, cultural, social, ethical and moral attitudes prevalent in individual countries towards human life and its origins. In particular, gamete and embryo donation, surrogacy and preimplantation genetic diagnosis are hot spots in MAR regulation in Europe.

Demand for infertility treatment on the rise The field of MAR is subject to the EU directive 2004/23/EC on quality and safety of human tissues and cells. "19 Member States have specific legislations in place for MAR, in the remaining eight countries, MAR is covered by the general health legislation," said Isabel de la Mata from the European Commission. "The organization of health systems is the exclusive competence of the members, meaning the legally allowed forms of treatment, the eligibility criteria and the reimbursement of treatments all vary between the Member States." And yet demand for MAR treatment is on the rise in Europe. The latest survey by ESHRE - the only one of its kind in Europe – found that 494,599 treatment cycles were performed in Europe in 2006 compared to 203,893 cycles ten years earlier. The number of clinics reporting to the survey increased from 482 to 1,016 during the same period. In several European countries 2-5% of children are born after MAR, with every one in six couples seeking some sort of medical assistance in order to achieve a pregnancy. 30,000 couples seek treatment outside their home countries

"Due to the inequality of reimbursement and treatment unavailability, many patients seek treatment outside their home country, often putting themselves and their unborn babies at risk," explained Clare Lewis Jones, Chair of Fertility Europe, the umbrella organization of patient associations in Europe. Cross border travel for reproductive care is becoming a relevant phenomenon in Europe. A recent study by ESHRE showed that an estimated 11,000 to 14,000 patients go abroad for treatment each year in the six European countries studied (Belgium, Czech Republic, Denmark, Switzerland, Spain and Slovenia). "We estimate that about 30,000 couples cross borders each year in Europe to receive assisted reproduction treatment," said Luca Gianaroli, chairman of ESHRE.

"Less restrictive reimbursement policies leading to increased accessibility and use of MAR would be incentives for the industry to increase development efforts in this area," said Joan-Carles Arce, Vice President of R&D at Ferring Pharmaceuticals. "In addition, funding of academia-industry collaborations would stimulate further research within MAR and facilitate that new treatment concepts are being developed and subsequently put into clinical practice. It would also have a beneficial impact on the drug development activities if pricing and reimbursement authorities rewarded innovation."

"ESHRE is concerned about the heterogeneity that still exists in Europe," explained Luca Gianaroli. "At the European level a serious and fundamental reflection of MAR legislation is necessary to ensure that treatments of proven benefit to patients and offspring are made available in Europe, irrespective of the patient's income, marital status and place of residence." ESHRE believes this discussion should take place together with professionals in the fields and patients.

INFORMATION: Workshop 3 "Reproductive health – Individual choices in reproductive health": Organised by the European Society of Human Reproduction and Embryology (ESHRE). Wednesday, 6. October 2010

www.eshre.eu
www.ehfg.org

ESHRE Press Contact:
Hanna Hanssen
Tel: +32 22 636466
Mob: +32 473 353381
hanna@eshre.eu


ELSE PRESS RELEASES FROM THIS DATE:

Greatest warming is in the north, but biggest impact on life is in the tropics

2010-10-07
In recent decades documented biological changes in the far Northern Hemisphere have been attributed to global warming, changes from species extinctions to shifting geographic ranges. Such changes were expected because warming has been fastest in the northern temperate zone and the Arctic. But new research published in the Oct. 7 edition of Nature adds to growing evidence that, even though the temperature increase has been smaller in the tropics, the impact of warming on life could be much greater there than in colder climates. The study focused on ectothermic, or ...

From eye to brain

From eye to brain
2010-10-07
LA JOLLA, CA-By comparing a clearly defined visual input with the electrical output of the retina, researchers at the Salk Institute for Biological Studies were able to trace for the first time the neuronal circuitry that connects individual photoreceptors with retinal ganglion cells, the neurons that carry visuals signals from the eye to the brain. Their measurements, published in the Oct. 7, 2010, issue of the journal Nature, not only reveal computations in a neural circuit at the elementary resolution of individual neurons but also shed light on the neural code used ...

Blood pressure breakthrough holds real hope for treatment of pre-eclampsia

2010-10-07
Scientists have discovered a mechanism which raises blood pressure in pre-eclampsia, a potentially deadly condition which occurs during pregnancy. After 20 years of research, scientists from the University of Cambridge have now cracked the first step in the main process that controls blood pressure. Their findings, published today in the journal Nature, are likely to have significant implications for the treatment of pre-eclampsia as well as high blood pressure (also known as hypertension). Blood pressure is controlled by hormones called angiotensins, which cause ...

Research identifies the herbal supplements that are effective in treating anxiety

2010-10-07
A systematic review of research into the use of nutritional supplements for the treatment of anxiety disorders has found strong evidence for the use of extracts of passionflower or kava and combinations of L-lysine and L-arginine. Researchers writing in BioMed Central's open access Nutrition Journal pooled the results of 24 studies involving a total of more than 2000 participants, showing that some nutritional and herbal supplements can be effective, without the risk of serious side effects. The research was carried out by Shaheen Lakhan and Karen Vieira from the Global ...

Stressed-out mums may worsen their child's asthma

2010-10-07
Mums who are often angry or irritated and those who suppress their emotional expressions can worsen the severity of their children's asthma symptoms, especially when the children are younger. Researchers writing in BioMed Central's open access journal BioPsychoSocial Medicine studied 223 mothers for a year , investigating how their stress levels, coping styles and parenting styles were associated with their 2 to 12 year old children's disease status. Jun Nagano, from the Kyushu University Institute of Health Science, Fukuoka, Japan, worked with a team of researchers ...

Novel approach yields new insights into the causes of pre-eclampsia

2010-10-07
An exciting collaboration between the Universities of Cambridge and Nottingham has resulted in new insights into the hypertension that frequently blights pregnancy. The results, published in the journal Nature [online 6th October], describe the solving of the first step in the principal process that controls blood pressure — the release of the hormone angiotensin from its source protein, angiotensinogen. Every day, millions of people are treated with drugs which either block the production of angiotensin, (ACE inhibitors), or stop it from taking effect in the body once ...

Vitamin D deficiency rampant in patients undergoing orthopedic surgery, damaging patient recovery

2010-10-07
Almost 50 percent of patients undergoing orthopedic surgery have vitamin D deficiency that should be corrected before surgery to improve patient outcomes, based on a study by researchers at Hospital for Special Surgery (HSS) in New York City. Vitamin D is essential for bone healing and muscle function and is critical for a patient's recovery. The study appears in the October issue of The Journal of Bone and Joint Surgery. "In the perfect world, test levels, fix and then operate," said Joseph Lane, M.D., professor of Orthopedic Surgery and chief of the Metabolic Bone Disease ...

Female Cantabrian bears and their young do not hibernate

Female Cantabrian bears and their young do not hibernate
2010-10-07
A team of Spanish scientists followed the brown bear population through the mountains of the Cantabrian Cordillera between 1998 and 2007 in order to find out about their hibernation habits, which had been questioned in historical documents. The results confirm that female bears with babies and independent young bears under the age of two do not usually hibernate, while the other bears follow normal hibernation patterns. Brown bears (Ursus arctos) all over the world hibernate, but according to historical documents this is not always the case. The Libro de la Montería by ...

Reviving the FDA: NEJM perspective

2010-10-07
Washington, DC – In a Perspective piece published online today in the New England Journal of Medicine, Georgetown University School of Medicine family medicine physician Susan Okie gives a comprehensive overview of change, and planned change, within the Food and Drug Administration (FDA). The review comes as the FDA's commissioner, Margaret Hamburg, completes her first year as the agency's leader. Okie writes that the FDA's priorities over the past year have included "finding ways to make the FDA more nimble and proactive, restoring its credibility and refocusing staff ...

Vultures use face flushing technique for instant status updates

2010-10-07
Tech savvy humans who use social media sites to instantly update their 'statuses', may be behaving like vultures who use 'face flushing' as a visible way of instantly updating their own status when interacting with peers and rivals. Research, published in Ethology, reveals how the ability to rapidly change skin colour is a key form of interaction for vultures, especially for displays of dominance. The ability to rapidly change skin colour has been well documented in reptiles and fish, which use specialist cells to disperse and concentrate pigments. However, the ability ...

LAST 30 PRESS RELEASES:

UCF receives prestigious Keck Foundation Award to advance spintronics technology

Cleveland Clinic study shows bariatric surgery outperforms GLP-1 diabetes drugs for kidney protection

Study reveals large ocean heat storage efficiency during the last deglaciation

Fever drives enhanced activity, mitochondrial damage in immune cells

A two-dose schedule could make HIV vaccines more effective

Wastewater monitoring can detect foodborne illness, researchers find

Kowalski, Salonvaara receive ASHRAE Distinguished Service Awards

SkAI launched to further explore universe

SLU researchers identify sex-based differences in immune responses against tumors

Evolved in the lab, found in nature: uncovering hidden pH sensing abilities

Unlocking the potential of patient-derived organoids for personalized sarcoma treatment

New drug molecule could lead to new treatments for Parkinson’s disease in younger patients

Deforestation in the Amazon is driven more by domestic demand than by the export market

Demand-side actions could help construction sector deliver on net-zero targets

Research team discovers molecular mechanism for a bacterial infection

What role does a tailwind play in cycling’s ‘Everesting’?

Projections of extreme temperature–related deaths in the US

Wearable device–based intervention for promoting patient physical activity after lung cancer surgery

Self-compassion is related to better mental health among Syrian refugees

Microplastics found in coral skeletons

Stroke rates increasing in individuals living with SCD despite treatment guidelines

Synergistic promotion of dielectric and thermomechanical properties of porous Si3N4 ceramics by a dual-solvent template method

Korean research team proposes AI-powered approach to establishing a 'carbon-neutral energy city’

AI is learning to read your emotions, and here’s why that can be a good thing

Antidepressant shows promise for treating brain tumors

European Green Deal: a double-edged sword for global emissions

Walking in lockstep

New blood test could be an early warning for child diabetes

Oceanic life found to be thriving thanks to Saharan dust blown from thousands of kilometers away

Analysis sheds light on COVID-19-associated disease in Japan

[Press-News.org] Reproductive health: Checkerboard of infertility treatment in Europe
In a number of European countries, infertility patients are limited in their choice for medically assisted reproduction treatment, experts criticized today at the European Health Forum Gastein. Many patients seek treatment outside their home countries